2020
DOI: 10.1016/j.neuroscience.2020.02.031
|View full text |Cite
|
Sign up to set email alerts
|

Musk Ketone Induces Neural Stem Cell Proliferation and Differentiation in Cerebral Ischemia via Activation of the PI3K/Akt Signaling Pathway

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
16
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(18 citation statements)
references
References 29 publications
2
16
0
Order By: Relevance
“…; 1.0, 5.0 mg/100 g, i.p Reducing the histamine and S-HT contents of the inflamed tissues [ 34 ] HUVEC Muscone 37.5, 75, 150 μg/mL Decreasing expression of CAMs on HUVEC [ 49 ] IL-1β induced end-plate chondrocytes; Rat model of endplate degeneration Muscone 6.25, 12.5, and 25 lmol/L; 10 mg/kg, p.o Blocking the proinflammatory effect of IL-1β in vitro; inhibiting inflammatory cytokine expression in degenerated IVDs, and prevent IVD degeneration in vivo [ 52 ] Murine BV2 microglial cells; adjuvant inflammatory pain model Muscone 1, 2, 4, 8, 16 μM; 4, 8, 16 mg/kg Suppressing microglial activation-mediated inflammatory response through the NOX4/JAK2-STAT3 pathway and NLRP3 inflammasome; inhibiting the CFA-induced NOX4, p-JAK2/p-STAT3, and NLRP3 inflammasome expression in the spinal cord of mice [ 54 ] Neuroprotective effects Glutamate-induced PC12 cells Muscone 0.1, 1, 10 μM Attenuating ROS generation and Ca2 + influx, via NR1 and CaMKII-depended ASK-1/JNK/p38 signaling pathways [ 61 ] MCAO rat model Muscone 1 mg/kg, i.g Down-regulating the expression of EAAC1mRNA in the ischemic hippocampus [ 62 ] MCAO rat model Muscone 1 mg/kg, i.g Reducing NR1 protein expression, thereby reducing excitatory glutamate toxicity [ 63 ] MCAO rat model; oxygen–glucose deprivation cell model Muscone 0.5, 1 mg/kg, i.g. ; 0.9, 1.8 μM Activating the PI3K/Akt signaling pathway [ 67 ] In vitro blood–brain barrier model ...…”
Section: Pharmacological Effectsmentioning
confidence: 99%
See 1 more Smart Citation
“…; 1.0, 5.0 mg/100 g, i.p Reducing the histamine and S-HT contents of the inflamed tissues [ 34 ] HUVEC Muscone 37.5, 75, 150 μg/mL Decreasing expression of CAMs on HUVEC [ 49 ] IL-1β induced end-plate chondrocytes; Rat model of endplate degeneration Muscone 6.25, 12.5, and 25 lmol/L; 10 mg/kg, p.o Blocking the proinflammatory effect of IL-1β in vitro; inhibiting inflammatory cytokine expression in degenerated IVDs, and prevent IVD degeneration in vivo [ 52 ] Murine BV2 microglial cells; adjuvant inflammatory pain model Muscone 1, 2, 4, 8, 16 μM; 4, 8, 16 mg/kg Suppressing microglial activation-mediated inflammatory response through the NOX4/JAK2-STAT3 pathway and NLRP3 inflammasome; inhibiting the CFA-induced NOX4, p-JAK2/p-STAT3, and NLRP3 inflammasome expression in the spinal cord of mice [ 54 ] Neuroprotective effects Glutamate-induced PC12 cells Muscone 0.1, 1, 10 μM Attenuating ROS generation and Ca2 + influx, via NR1 and CaMKII-depended ASK-1/JNK/p38 signaling pathways [ 61 ] MCAO rat model Muscone 1 mg/kg, i.g Down-regulating the expression of EAAC1mRNA in the ischemic hippocampus [ 62 ] MCAO rat model Muscone 1 mg/kg, i.g Reducing NR1 protein expression, thereby reducing excitatory glutamate toxicity [ 63 ] MCAO rat model; oxygen–glucose deprivation cell model Muscone 0.5, 1 mg/kg, i.g. ; 0.9, 1.8 μM Activating the PI3K/Akt signaling pathway [ 67 ] In vitro blood–brain barrier model ...…”
Section: Pharmacological Effectsmentioning
confidence: 99%
“…Muscone can promote neural stem cell proliferation and differentiation to protect against cerebral ischemia. This effect is attributed to the activation of the PI3K/Akt signaling pathway [ 67 ]. Cerebral ischemia is accompanied by edema, and this symptom may lead to death [ 68 ].…”
Section: Pharmacological Effectsmentioning
confidence: 99%
“…PDK1 phosphorylates Akt proteins, involved in cell growth and survival (Hers et al, 2011). PI3K/Akt signaling can be activated in response to different cues such as reactive oxygen species (ROS) (Le Belle et al, 2011), chaperone proteins (Huang and Wang 2018) or even phytochemicals (Lu et al, 2020;Zhou et al, 2020) to promote NSCs' proliferation. In low hypoxic conditions, niche components secrete vascular endothelial growth factor (VEGF) or brain derived neurotrophic factor (BDNF) that rise PI3K, Akt and JNK…”
Section: B Mapk/erk and Akt Signalingmentioning
confidence: 99%
“…Moreover, after oxygen-glucose deprivation, glucose-regulated protein 78 exercises anti-apoptotic and proliferative effects through PI3K/Akt and ERK1/2 pathways (Liu et al, 2018). Phytochemicals, such as astragalosides (Chen et al, 2019;Sun et al, 2020) and musk ketone (Zhou et al, 2020), that were known for their beneficial post-stroke effects, decrease apoptosis and enhance proliferation by regulating EGFR/MAPK and PI3K/Akt signaling. Other study identified miR-145 as an important regulator of NSCs' function after ischemia through MAPK pathway, that leads to decreased levels of Cleaved-caspase 3 and increased levels of Cyclin D1.…”
Section: Biomedicalmentioning
confidence: 99%
“…After cerebral ischemic injury, the PI3K/AKT pathway is activated and involved in cell proliferation, differentiation ( Zhou et al, 2020 ), angiogenesis ( Chen et al, 2019 ), and survival ( Beker et al, 2019 ). The activation of the PI3K/AKT signaling pathway is related to the increase in many growth-stimulating factors, angiogenic molecules, and vascular endothelial growth factor.…”
Section: Introductionmentioning
confidence: 99%